Effect of TXA on Reducing Bruising After Filler Injection

Part of paid clinical trials in Madison, Wisconsin.

Sponsor
University of Wisconsin, Madison
Study ID
NCT06665594
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Facial Filler Injections
  • Hyaluronic Acid
  • Tranexamic Acid

Eligibility Criteria

Sex
ALL
Age
18 Years - 89 Years
Healthy Volunteers
Accepted

Interventions

  • Hyaluronic Acid (HA) — PROCEDURE
    Injectable gel
  • Tranexamic Acid (TXA) — DRUG
    Injection of TXA
  • Saline (placebo) — DRUG
    Injection of saline

Study Details

The goal of this clinical trial is to look at the effect tranexamic acid (TXA) may have on reducing bruising, swelling, and pain after facial filler injection. The main question it aims to answer is: * Does the addition of TXA to hyaluronic acid (HA) reduce bruising, swelling, and tenderness after HA injection? Participants will receive the study medication along with the standard facial filler injection and complete surveys.

Key Dates

Start date
Dec 5, 2025
Status verified
Sep 2025
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026

Study Design

Enrollment
40 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Facial Filler Injection
    TXA plus HA injection in half of face, saline plus HA injection on other half of face

Primary Outcome Measure

Intensity of bruising on TXA + HA half of face [ Time Frame: Post-procedure day 7 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Wisconsin - MadisonMadisonWisconsin53705
Armin Edalatpour, MD
[email protected]
608-263-7502
Daniel Y Cho, MD, PhD (PRINCIPAL_INVESTIGATOR)
Ahmed Afifi, MD (SUB_INVESTIGATOR)
Jeffrey D Larson, MD (SUB_INVESTIGATOR)
Armin Edalatpour, MD (SUB_INVESTIGATOR)
Ellen C Shaffrey, MD (SUB_INVESTIGATOR)
Peter J Wirth, MD (SUB_INVESTIGATOR)

Find similar trials in Madison, WI

By research site
University of Wisconsin - Madison· Madison, WI

Related Studies